 |
AC451 |
Multiple organ condyloma acuminatum tissue array, 45 cases 45 cores
|
US Biomax |
|
331 |
|
Publication |
 |
AD2081 |
Adrenal gland disease spectrum (adrenal cancer progression) tissue array, 100 cases 200 cores
|
US Biomax |
|
456 |
|
Publication |
 |
AG801 |
Adrenal tumor tissue array, 80 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
 |
AMS541 |
Mouse(FBV strain) normal tissue array, cover 22 organs anatomic sites, 3 cases 54 cores
|
US Biomax |
|
225 |
|
Publication |
 |
AMS542 |
Mouse(KM strain) normal tissue array, cover 22 organs anatomic sites, 3 cases 54 cores
|
US Biomax |
|
225 |
|
Publication |
 |
AMS544 |
Mouse normal tissue array, covering 22 organ anatomic sites, 3 cases 54 cores
|
US Biomax |
|
225 |
|
Publication |
 |
ART661 |
Rat(Wistar strain) normal tissue array, covering all major organs, non overlapping with ART662, 22 cases 66 cores
|
US Biomax |
|
225 |
|
Publication |
 |
ASM221 |
Cyno monkey normal tissue array, 22 cases 22 cores
|
US Biomax |
|
225 |
|
Publication |
 |
BB01011 |
Gastric ulcer tissue array, 14 cases 24 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC000110 |
Colorectal cancer tissue array, 85 cases 170 cores
|
US Biomax |
|
397 |
|
Publication |
 |
BC000111 |
Multiple organ cancer tissue array, 39 cases 39 cores
|
US Biomax |
|
189 |
|
Publication |
 |
BC000119 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BC00012 |
Multiple organ diseased tissue array, 30 cases 60 cores, replaced by MC801
|
US Biomax |
|
160 |
|
Publication |
 |
BC000120 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BC00014 |
Multiple organ diseased tissue array, 63 cases 63 cores, replaced by MC631
|
US Biomax |
|
160 |
|
Publication |
 |
BC00016 |
Multiple organ diseased tissues, 54 cases 54 cores, replaced by MC541
|
US Biomax |
|
160 |
|
Publication |
 |
BC00019 |
Multiple organ squamous cell carcinoma tissue array, 63 cases 63 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC00111 |
Multiple organ normal and diseased tissue array (replaced by MCN601), 54 cases 60 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC001111 |
Multiple organ normal and diseased tissue array, 58 cases 60 cores, replaced by MCN601
|
US Biomax |
|
231 |
|
Publication |
 |
BC001113 |
Esophageal adenocarcinoma, cardia adenocarcinoma, normal esophageal and cardia tissue array, 50 cases 50 cores (previously cat ES501)
|
US Biomax |
|
189 |
|
Publication |
 |
BC00112 |
Multiple organ paired normal and cancer (8 types) tissue array, 48 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC001128 |
Top five cancer tissue array, including TNM and pathology grade, 148 cases 175 cores
|
US Biomax |
|
485 |
|
Publication |
 |
BC00113 |
Multiple organs tumor and normal tissue, 48 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
 |
BC001130 |
Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores
|
US Biomax |
|
278 |
|
Publication |
 |
BC001134 |
Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 cores
|
US Biomax |
|
397 |
|
Publication |
 |
BC00114 |
Multiple organ normal and diseased tissue array, 36 cases 60 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC00115 |
Multiple organ normal and diseased tissue array, 44 cases 64 cores, replaced by MC802
|
US Biomax |
|
231 |
|
Publication |
 |
BC00116 |
Carcinoma with adjacent tissue combined panel tissue array, 44 cases 48 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC00119 |
Multiple organ diseased tissue array, 32 cases 32 cores, replaced by MC483
|
US Biomax |
|
160 |
|
Publication |
 |
BC00432 |
Multiple organ tumor and adjacent normal tissue array, 39 cases 43 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC01001 |
Tissue array of gastric diseases biopsied from gastroscope, including TNM, clinical stage and pathology grade, 18 cases 18 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC01011 |
Stomach carcinoma (multi tissue combined panel) tissue array, 24 cases 72 cores, replaced by ST721
|
US Biomax |
|
160 |
|
Publication |
 |
BC01014 |
Stomach carcinoma tissue array (multi tissue combined panel), 71 cases 72 cores, replaced by ST807
|
US Biomax |
|
231 |
|
Publication |
 |
BC01022 |
Stomach adenocarcinoma (combination of adjacent and normal) tissue array, 21 cases 63 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC01023 |
Stomach adenocarcinoma (combination of adjacent and normal) tissue array, 21 cases 63 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC01024 |
Stomach adenocarcinoma (combination of adjacent and normal) tissue array, 21 cases 63 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC01071 |
Carcinoma of stomach, liver and rectum tissue array, 45 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC01071a |
Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed
|
US Biomax |
|
185 |
|
Publication |
 |
BC01081 |
Adenocarcinoma of stomach, colon and rectum high density tissue array, 556 cases 616 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BC01114 |
Stomach adenocarcinoma with matched adjacent tissue and normal tissue array, including TNM, clinical stage and pathology grade, 55 cases 100 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC02011 |
Multiple esophageal cancer tissue array, 69 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC02012 |
Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC02013 |
Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC02021 |
Esophagus squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC02022 |
Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC02023 |
Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases 54cores, replaced by ES722
|
US Biomax |
|
160 |
|
Publication |
 |
BC02111 |
Esophagus adenocarcinoma and normal tissue array, 23 cases 80 cores
|
US Biomax |
|
189 |
|
Publication |
 |
BC03002 |
Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BC03011 |
Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010; ihc Anti-PCNA confirmed
|
US Biomax |
|
185 |
|
Publication |
 |
BC03011 |
Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010
|
US Biomax |
|
160 |
|
Publication |
 |
BC03013 |
Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV723
|
US Biomax |
|
160 |
|
Publication |
 |
BC03021 |
Liver carcinoma (combination of adjacent and normal) tissue array, 42 cases 63 cores, replaced by LV803
|
US Biomax |
|
231 |
|
Publication |
 |
BC03116 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC03118 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BC03119 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores
|
US Biomax |
|
278 |
|
Publication |
 |
BC04002 |
Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases 100 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BC04011 |
Lung cancer tissue array, including pathology grade, 23 cases 63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
185 |
|
Publication |
 |
BC04012 |
Lung carcinoma (multi tissue combined panel) tissue array, 68 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC04013 |
Non small cell lung carcinoma tissue array, 63 cases 63 core, replaced by LC806
|
US Biomax |
|
160 |
|
Publication |
 |
BC04014 |
Non small cell lung carcinoma (NSCLC) tissue array, 63 cases 63 cores, replaced by LC807
|
US Biomax |
|
160 |
|
Publication |
 |
BC04015 |
Lung carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC04016 |
Lung carcinoma tissue array, 72 cases 72 cores, replaced by LC726
|
US Biomax |
|
160 |
|
Publication |
 |
BC04021 |
Lung carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC04022 |
Non small cell lung carcinoma (NSCLC)(combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC041114 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BC041115 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores
|
US Biomax |
|
278 |
|
Publication |
 |
BC041115a |
Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed
|
US Biomax |
|
296 |
|
Publication |
 |
BC04118 |
Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC04119 |
Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b
|
US Biomax |
|
231 |
|
Publication |
 |
BC04119b |
Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases 40 cores, replacing BC04119
|
US Biomax |
|
336 |
|
Publication |
 |
BC05002 |
Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BC05011 |
Multiple types of colon carcinoma tissue array, 72 cases 72 cores, replaced by CO804
|
US Biomax |
|
231 |
|
Publication |
 |
BC050112 |
Colon metastatic carcinoma tissue array, 23 cases 63 cores, replaced by CO726
|
US Biomax |
|
231 |
|
Publication |
 |
BC05012 |
Colon carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores.
|
US Biomax |
|
231 |
|
Publication |
 |
BC05021 |
Colon adenocarcinoma (combination of adjacent and adjacent normal) tissue array, 18 cases 54 cores, no overlapping with BC05022, replaced by CO722
|
US Biomax |
|
231 |
|
Publication |
 |
BC05022 |
Colon adenocarcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, no overlapping with BC05021
|
US Biomax |
|
231 |
|
Publication |
 |
BC05023 |
Colon adenocarcinoma (combination of adjacent and normal) tissue array, with grade and stage (TNM) info, 18 cases 54 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC051110 |
Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores
|
US Biomax |
|
278 |
|
Publication |
 |
BC051111 |
Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BC05115 |
Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702
|
US Biomax |
|
231 |
|
Publication |
 |
BC05118 |
Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BC05118a |
Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed
|
US Biomax |
|
296 |
|
Publication |
 |
BC06002 |
Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases 72 cores
|
US Biomax |
|
321 |
|
Publication |
 |
BC06011 |
Rectum carcinoma (multi tissue combined panel) tissue array, 71 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC06022 |
Rectum carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by RE722
|
US Biomax |
|
160 |
|
Publication |
 |
BC07001 |
Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases 80 cores
|
US Biomax |
|
321 |
|
Publication |
 |
BC07011 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replaced by BC07013
|
US Biomax |
|
160 |
|
Publication |
 |
BC07012 |
Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores, replaced by BC07015
|
US Biomax |
|
160 |
|
Publication |
 |
BC07013 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replacing BC07011
|
US Biomax |
|
160 |
|
Publication |
 |
BC07014 |
Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC07014a |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed
|
US Biomax |
|
185 |
|
Publication |
 |
BC07015 |
Multiple type kidney cancer tissue array with normal tissues, 71 cases 72 cores, replacing BC07012
|
US Biomax |
|
231 |
|
Publication |
 |
BC07114 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 100 cases 200 cores
|
US Biomax |
|
558 |
|
Publication |
 |
BC07115 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 120 cases 120 cores
|
US Biomax |
|
321 |
|
Publication |
 |
BC08013 |
Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BC08014
|
US Biomax |
|
160 |
|
Publication |
 |
BC08014 |
Breast cancer (multiple types of breast cancer) tissue array, 63 cases 63 cores, replaced by BR8018
|
US Biomax |
|
160 |
|
Publication |
 |
BC08015 |
Breast carcinoma (multi tissue combined panel) tissue array, 22 cases 63 cores, replaced by BR728
|
US Biomax |
|
160 |
|
Publication |
 |
BC08016 |
Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BR803
|
US Biomax |
|
160 |
|
Publication |
 |
BC08022 |
Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases 63 cores, replacing BN08021
|
US Biomax |
|
160 |
|
Publication |
 |
BC08023 |
Breast carcinoma (combination of adjacent and normal) tissue array, 57 cases 63 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC08032 |
Infiltrating duct carcinoma (combination of adjacent and normal) tissue array, 57 cases 63 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC081115 |
Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120
|
US Biomax |
|
278 |
|
Publication |
 |
BC081116 |
Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores
|
US Biomax |
|
278 |
|
Publication |
 |
BC081120 |
Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases 110 cores, replacing BC081115
|
US Biomax |
|
266 |
|
Publication |
 |
BC08118 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases 100 cores
|
US Biomax |
|
321 |
|
Publication |
 |
BC09012 |
Endometrial carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC10021 |
Cervix carcinoma (combination of margin and normal tissues) tissue array, 64 cases 72 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC10025 |
Cervical cancer and normal tissue array, 54 cases 54 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC11011 |
Ovarian carcinoma (multi tissue combined panel) tissue array (replaced by OV802), 70 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC110118 |
Ovarian cancer tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC11012
|
US Biomax |
|
231 |
|
Publication |
 |
BC11012 |
Ovarian carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC11012a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed
|
US Biomax |
|
185 |
|
Publication |
 |
BC111109 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC111110 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC11115 |
Ovary serous papillary adenocarcinoma, lymph node metastasis with adjacent normal ovary tissue array, including TNM and pathology grade, 100 cases 100 cores
|
US Biomax |
|
321 |
|
Publication |
 |
BC12011a |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed
|
US Biomax |
|
162 |
|
Publication |
 |
BC12012 |
Bladder carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BL802
|
US Biomax |
|
231 |
|
Publication |
 |
BC15012 |
Thyroid carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC17012 |
Medulloblastoma of brain tissue array, 100 cases 100 cores
|
US Biomax |
|
277 |
|
Publication |
 |
BC17013 |
Brain astrocytoma and meningioma tissue array, 120 cases 120 cores
|
US Biomax |
|
321 |
|
Publication |
 |
BC19012 |
Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores, replaced by PR808
|
US Biomax |
|
231 |
|
Publication |
 |
BC19013 |
Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC19014 |
Prostate carcinoma tissue array, 31 cases 63 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC19015 |
Prostate carcinoma tissue array, 9 cases 27 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC19017 |
Prostate carcinoma tissue array, 33 cases 63 cores, replaced by PR809
|
US Biomax |
|
160 |
|
Publication |
 |
BC19019 |
Prostate cancer and hyperplasia tissue array, 33 cases 63 cores, replacing BC19011
|
US Biomax |
|
231 |
|
Publication |
 |
BC19021 |
Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases 72 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BC19111 |
Normal prostate tissue array, with prostate tumor and hyperplasia, 11 cases 30 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC21011 |
Skin malignant tumor tissue array, 78 cases 78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014
|
US Biomax |
|
231 |
|
Publication |
 |
BC21014 |
Skin malignant tumor tissue array, 78 cases 78 cores, replacing BC21011
|
US Biomax |
|
231 |
|
Publication |
 |
BC23011 |
Testis tumor combination, 24 cases 72 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC23012 |
Testis tumor tissue array, 23 cases 63 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC24011 |
Soft tissue tumor (multi tissue combined panel) tissue array, 63 cases 63 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC24021 |
Leiomyosarcoma and Rhabdomyosarcoma tissue array with normal muscles controls, 39 cases 75 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC27011 |
Multiple organs, diseased tissue array of oral cavity, 47 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
 |
BC30011 |
Heart tissue array, 13 cases 34 cores, replaced by BC30013
|
US Biomax |
|
231 |
|
Publication |
 |
BC30013 |
Heart disease and normal tissue array, replacing BC30011, 18 cases 36 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BC34011 |
Head and neck squamous cell carcinoma tissue array, 24 cases 63 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BC34111 |
Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases 72 cores, replaced by HN811
|
US Biomax |
|
160 |
|
Publication |
 |
BC35111 |
Retinoblastoma and normal adjacent tissue array, 17 cases 34 cores
|
US Biomax |
|
189 |
|
Publication |
 |
BCN721 |
Multiple cancer (12 common types) tissue array with unmatched normal adjacent tissue, 71 cases 72 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BCN801 |
Multiple organ cancer with adjacent tissue combined panel tissue array, 48 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BCN961 |
Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases 96 cores, replaced by BCN963
|
US Biomax |
|
231 |
|
Publication |
 |
BCN962 |
Combined multiple normal and cancer tissue array, containing germline, embryonic tumors and normal adjacent tissue, 60 cases 96 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BCN963 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961
|
US Biomax |
|
266 |
|
Publication |
 |
BCN963a |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed
|
US Biomax |
|
258 |
|
Publication |
 |
BE01014 |
Multiple organ, normal fetus tissue array, 26 cases 78 cores
|
US Biomax |
|
189 |
|
Publication |
 |
BE01015 |
Multiple organ, normal fetus tissue array, 50 cases 50 cores
|
US Biomax |
|
189 |
|
Publication |
 |
BL1001 |
Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BL1002 |
Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases 100 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BL1501 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258 |
|
Publication |
 |
BL1921 |
Mid advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BL208 |
Tissue microarray of bladder cancer and normal tissue, high density (69 cases 208 cores) with grade and stage data
|
US Biomax |
|
456 |
|
Publication |
 |
BL2081 |
Bladder cancer high density tissue array, 203 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BL2082 |
Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BL241 |
Bladder cancer tissue array with self matching normal adjacent tissues, 10 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
 |
BL242 |
Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
 |
BL243 |
Bladder cancer tissue array with normal tissues from autopsy, 12 cases 24 cores with stage and grade data
|
US Biomax |
|
100 |
|
Publication |
 |
BL244 |
Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105 |
|
Publication |
 |
BL481 |
Bladder cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores, with stage and grade data
|
US Biomax |
|
189 |
|
Publication |
 |
BL482 |
Bladder cancer tissue array, including TNM and pathology grade, 48 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
 |
BL801 |
Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases 80 cores, replaced by BL806
|
US Biomax |
|
266 |
|
Publication |
 |
BL802 |
Bladder cancer tissue array with normal tissue, 80 cases 80 cores, replacing BC12012
|
US Biomax |
|
266 |
|
Publication |
 |
BL803 |
Bladder cancer and normal tissue array with TNM and grade data, 40 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BL804 |
Bladder disease spectrum (urocystic cancer progression) tissue array, 80 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BL805 |
Mid advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BL806 |
Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BL801
|
US Biomax |
|
266 |
|
Publication |
 |
BLC1501 |
Bladder cancer mid density tissue array, 75 cases 150 cores
|
US Biomax |
|
261 |
|
Publication |
 |
BLC241 |
Bladder cancer tissue array, 12 cases 24 cores
|
US Biomax |
|
189 |
|
Publication |
 |
BLC661 |
Bladder cancer tissue array, 33 cases 66 cores
|
US Biomax |
|
225 |
|
Publication |
 |
BM01011 |
Liver, kidney, lung, muscle, brain, heart, stomach, spleen tissue array, 160 cases 160 cores, replaced by MO1601
|
US Biomax |
|
278 |
|
Publication |
 |
BM241 |
Bone marrow tissue array, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
 |
BM481 |
Normal bone marrow tissue array, 24 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BM482 |
Multiple myeloma tissue microarray with normal tissue as control, 24 cases 48 cores, replaced by BM483
|
US Biomax |
|
397 |
|
Publication |
 |
BM483 |
Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases 48 cores, replacing BM482
|
US Biomax |
|
266 |
|
Publication |
 |
BN00011 |
Multiple organ normal tissue array, 48 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BN00015 |
Multiple organ normal tissue array, 47 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BN00112 |
Multiple organ normal tissue array, 40cases 40 cores, replaced by BN00119
|
US Biomax |
|
160 |
|
Publication |
 |
BN00119 |
Multiple organ normal tissue array, 40 cases 40 cores, replacing BN00112
|
US Biomax |
|
266 |
|
Publication |
 |
BN01011 |
Normal stomach tissue (multi sites) array, 21 cases 63 cores, replaced by BN01011b
|
US Biomax |
|
160 |
|
Publication |
 |
BN01011b |
Normal stomach tissue array, 24 cases 72 cores, replacing BN01011
|
US Biomax |
|
277 |
|
Publication |
 |
BN01013 |
Normal stomach tissue (multi sites) array, 70 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BN03011 |
Normal liver tissue array (multi sites), 20 cases 63 cores, replaced by LVN801
|
US Biomax |
|
160 |
|
Publication |
 |
BN04011 |
Normal lung tissue (multi sites) tissue array, 22 cases 63 cores, replaced by LC725
|
US Biomax |
|
160 |
|
Publication |
 |
BN05011 |
Normal colon tissue (multi site) array, 23 cases 63 cores, replaced by BN05014
|
US Biomax |
|
160 |
|
Publication |
 |
BN05014 |
Colon normal tissue array, including TNM and pathology grade of 3 cases adenocarcinoma, 24 cases 72 cores, replacing BN05011
|
US Biomax |
|
160 |
|
Publication |
 |
BN06011 |
Normal rectum tissue (multi sites) tissue array, 23 cases 63 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BN06012 |
Normal rectum tissue (multi sites) tissue array, 70 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BN07011 |
Normal kidney tissue array (multi sites), 20 cases 54 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BN07012 |
Normal kidney tissue (multi sites) tissue array, 70 cases 72 cores, replaced by KD803
|
US Biomax |
|
160 |
|
Publication |
 |
BN08013 |
Normal breast tissue (multi sites) array, 71 cases 72 cores, replaced by BRN801
|
US Biomax |
|
160 |
|
Publication |
 |
BN08111 |
Breast hyperplasia and normal tissue array, 10 cases 30 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BN1002 |
Multiple organ (20) normal tissue array, 100 cases 100 cores, replacing BN1001
|
US Biomax |
|
266 |
|
Publication |
 |
BN1002a |
Multiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmed
|
US Biomax |
|
296 |
|
Publication |
 |
BN113 |
Multiple organ normal tissue array, replaced by BN126, 45 cases 45 cores
|
US Biomax |
|
189 |
|
Publication |
 |
BN114 |
Multiple normal human organ tissue array, 48 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
 |
BN115 |
Multiple organ normal tissue array, 46 cases 46 cores
|
US Biomax |
|
189 |
|
Publication |
 |
BN116 |
Multiple organ normal tissue array, 48 cases 48 cores, replaced by BN129
|
US Biomax |
|
189 |
|
Publication |
 |
BN117 |
Multiple organ normal tissue array, 45 cases 45 cores
|
US Biomax |
|
189 |
|
Publication |
 |
BN126 |
Multiple organ normal tissue array, replacing BN113, 45 cases 45 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BN129 |
Multiple organ adjacent normal tissue array, 48 cases 48 cores, replacing BN116
|
US Biomax |
|
160 |
|
Publication |
 |
BN242 |
Multiple normal (12 type) tissue array, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
 |
BN243 |
Multiple normal (12 type) tissue array, 12 cases 24 cores, replacing BN241
|
US Biomax |
|
88 |
|
Publication |
 |
BN243a |
Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed
|
US Biomax |
|
105 |
|
Publication |
 |
BN29011 |
Normal bone marrow tissue array, 60 cases 60 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BN481 |
Multiple human normal organ (12 type) tissue microarray, 24 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BN482 |
Normal human tissue microarray from 12 organs from autopsy, 24 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BN484 |
Multiple organ normal tissue array, 24 cases 48 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BN501 |
Normal human top 10 organ tissue array, 50 cases 50 cores, replacing BN00012 and BN00013
|
US Biomax |
|
160 |
|
Publication |
 |
BN961 |
Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases 102 cores, replacing BN861
|
US Biomax |
|
266 |
|
Publication |
 |
BO2081 |
Bone disease spectrum (bone tumor progression) tissue array, 104 cases 208 cores
|
US Biomax |
|
516 |
|
Publication |
 |
BO241 |
Bone and cartilage cancer tissue array with unmatched normal adjacent tissues, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
 |
BO242 |
Human normal bone tissue array, 12 cases 24 cores, replaced by BO243
|
US Biomax |
|
100 |
|
Publication |
 |
BO243 |
Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replaced by BO244
|
US Biomax |
|
88 |
|
Publication |
 |
BO244 |
Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replacing BO243
|
US Biomax |
|
100 |
|
Publication |
 |
BO244a |
Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105 |
|
Publication |
 |
BO481 |
Bone and cartilage tumor tissue array with unmatched normal tissue, 48 cases 48 cores with TNM data
|
US Biomax |
|
189 |
|
Publication |
 |
BO601 |
Bone giant cell tumor tissue array, 30 cases 60 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BO801 |
Bone and cartilage disease spectrum (bone and cartilage cancer progression) tissue array, 80 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BR01015 |
Multiple organ, normal tissue array, 8 normal tissues, 160 cases 160 cores, replacing BR01011
|
US Biomax |
|
278 |
|
Publication |
 |
BR041 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 4 cores, replaced by BR042a
|
US Biomax |
|
88 |
|
Publication |
 |
BR042a |
Breast cancer tissue array, including TNM and pathology grade, 4 cases 4 cores
|
US Biomax |
|
88 |
|
Publication |
 |
BR082 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 8 cores
|
US Biomax |
|
112 |
|
Publication |
 |
BR1001 |
Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases 100 cores, replaced by BR1004
|
US Biomax |
|
314 |
|
Publication |
 |
BR10010 |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004
|
US Biomax |
|
314 |
|
Publication |
 |
BR10010a |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme
|
US Biomax |
|
296 |
|
Publication |
 |
BR1002 |
Tissue microarray of breast cancer and normal tissue, 97 cases 100 cores, with stage and grade information
|
US Biomax |
|
266 |
|
Publication |
 |
BR1003 |
Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data
|
US Biomax |
|
266 |
|
Publication |
 |
BR1004 |
Tissue array of breast carcinoma and matched metastasis in lymph nodes tissue arrays, 50 cases 100 cores, replaced by BR10010
|
US Biomax |
|
314 |
|
Publication |
 |
BR1005 |
Breast cancer and matched metastatic carcinoma of lymph node, 50 cases 100 cores, no overlaps with BR1001 or BR1004
|
US Biomax |
|
314 |
|
Publication |
 |
BR1005a |
Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed
|
US Biomax |
|
296 |
|
Publication |
 |
BR1006 |
Breast tumor tissue array of varieties and normal adjacent tissue (NAT), 50 cases 100 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BR1007 |
Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BR1008 |
Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212
|
US Biomax |
|
266 |
|
Publication |
 |
BR1009 |
Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases 100 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BR1502 |
Breast cancer mid density tissue array, wiht AR ER PR Her 2 P53 EGFR Ki67 IHC results, 75 cases 150 cores, replaced by BR1503
|
US Biomax |
|
278 |
|
Publication |
 |
BR1503 |
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502
|
US Biomax |
|
278 |
|
Publication |
 |
BR1503a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti-
|
US Biomax |
|
296 |
|
Publication |
 |
BR1504 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BR1505 |
Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin
|
US Biomax |
|
296 |
|
Publication |
 |
BR1921 |
High density breast invasive ductal and lobular carcinoma tissue array with normal tissues, grading and staging data,192 cases 192 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR1922 |
Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR2001 |
Breast cancer high density tissue array, 196 cases 200 cores, replaced by BR2086
|
US Biomax |
|
456 |
|
Publication |
 |
BR208 |
High density, multiple breast cancer (1 3 grade) and normal breast tissue array, 70 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20810 |
Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20811 |
Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20812 |
Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20813 |
Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20814 |
Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20815 |
Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20816 |
Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20817 |
Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20818 |
Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20819 |
Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR2082 |
Breast disease spectrum (breast cancer progression) tissue array, 206 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20820 |
Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20821 |
Breast tumor survey tissue array (15 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20822 |
Breast tumor survey tissue array (16 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20823 |
Breast tumor survey tissue array (17 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20824 |
Breast tumor survey tissue array (18 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20825 |
Breast tumor survey tissue array (19 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20826 |
Breast tumor survey tissue array (20 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20827 |
Breast tumor survey tissue array (21 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20828 |
Breast tumor survey tissue array (22 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20829 |
Breast tumor survey tissue array (23 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR2083 |
High density breast cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20830 |
Breast tumor survey tissue array (24 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20831 |
Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20832 |
Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20833 |
Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20834 |
Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20835 |
Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR20836 |
Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR2085a |
High density (188 cases 208 cores), multiple types of breast cancer of infiltrating ductal, lobular carcinoma and normal breast tissue array, replaced by BR2085c.
|
US Biomax |
|
456 |
|
Publication |
 |
BR2085b |
High density (188 cases 208 cores), multiple types of breast cancer tissue array of infiltrating ductal, lobular carcinoma and normal breast
|
US Biomax |
|
456 |
|
Publication |
 |
BR2085c |
Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a
|
US Biomax |
|
456 |
|
Publication |
 |
BR2086 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001
|
US Biomax |
|
456 |
|
Publication |
 |
BR2087 |
Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR2088 |
Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR2089 |
Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR208b |
TMA block of high density (70 cases 208 cores), multiple breast cancer (I 3 grade) and normal breast tissue
|
US Biomax |
|
40981 |
|
Publication |
 |
BR2161 |
Breast cancer tissue array, including TNM and pathology grade, 216 cases 216 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR241 |
Breast cancer test tissue array with self matched or unmatched normal adjacent tissues, 6 cases 24 cores.
|
US Biomax |
|
88 |
|
Publication |
 |
BR242 |
Multiple breast cancer test tissue array with unmatched normal adjacent tissues, 12 cases 24 cores, replaced by BR244
|
US Biomax |
|
88 |
|
Publication |
 |
BR243 |
Breast cancer and adjacent normal tissue array, 6 cases 24 cores, replaced by BR243a
|
US Biomax |
|
88 |
|
Publication |
 |
BR243a |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243
|
US Biomax |
|
99 |
|
Publication |
 |
BR243b |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed
|
US Biomax |
|
90 |
|
Publication |
 |
BR243c |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed
|
US Biomax |
|
90 |
|
Publication |
 |
BR243d |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed
|
US Biomax |
|
90 |
|
Publication |
 |
BR243e |
Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed
|
US Biomax |
|
90 |
|
Publication |
 |
BR243f |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed
|
US Biomax |
|
90 |
|
Publication |
 |
BR244 |
Breast cancer tissue array with adjacent normal tissues, with TNM and grade info, 12 cases 24 cores, replaced by BR245
|
US Biomax |
|
88 |
|
Publication |
 |
BR245 |
Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246
|
US Biomax |
|
88 |
|
Publication |
 |
BR246 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a
|
US Biomax |
|
88 |
|
Publication |
 |
BR246a |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246
|
US Biomax |
|
99 |
|
Publication |
 |
BR247 |
Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections sllide
|
US Biomax |
|
189 |
|
Publication |
 |
BR451 |
Breast cancer tissue microarray with matched normal adjacent tissue and metastatic lymph nodes, 45cases 45 cores, with ER, PR and P53 IHC results
|
US Biomax |
|
160 |
|
Publication |
 |
BR480 |
Breast disease spectrum tissue array progression array, 48 cases 48 cores
|
US Biomax |
|
314 |
|
Publication |
 |
BR481 |
Breast infiltrating ductal carcinoma not otherwise specified (NOS) and matched adjacent, 12 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BR482 |
Multiple breast cancer tissue array with normal tissues from autopsy, 24 cases 48 cores, with stage and grade info
|
US Biomax |
|
160 |
|
Publication |
 |
BR483 |
Multiple breast cancer tissue array with normal tissues from autopsy, with TNM, 48 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BR484 |
Breast cancer tissue array, including TNM and pathology grade, 48 cases 48 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BR485 |
Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases 96 cores
|
US Biomax |
|
397 |
|
Publication |
 |
BR486 |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225 |
|
Publication |
 |
BR601 |
Breast fibroma and sclerosing adenosis tissue microarray, 30 cases 60 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BR602 |
Breast tumor and normal tissue array, with TNM data, 25 cases 60 cores
|
US Biomax |
|
0 |
|
Publication |
 |
BR6161 |
High density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases 616 cores
|
US Biomax |
|
753 |
|
Publication |
 |
BR641 |
Breast cancer tissue array, 64 cases 66 cores, with TNM data
|
US Biomax |
|
0 |
|
Publication |
 |
BR701 |
Breast cancer tissue array, 70 cases 70 cores, with TNM data plus ER, PR and Her 2 (C erbB 2, neu< em>) IHC results, replaced by BR962
|
US Biomax |
|
231 |
|
Publication |
 |
BR721 |
Breast cancer tissue array with self matching adjacent tissue and normal tissue, 24 cases 72 cores, no overlaps with other BR TMAs
|
US Biomax |
|
231 |
|
Publication |
 |
BR722 |
Breast disease spectrum tissue array, 66 cases 72 cores, including normal, precancerous and cancer in different stages
|
US Biomax |
|
231 |
|
Publication |
 |
BR723 |
Breast various pathology developmental process tissue array, including TNM and pathology grade, 71 cases 72 cores
|
US Biomax |
|
314 |
|
Publication |
 |
BR724 |
Breast cancer, adjacent and adjacent normal tissue array, 66 cases 72 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BR725 |
Breast cancer, adjacent and adjacent normal tissue array, 68 cases 72 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BR726 |
Breast cancer tissue array and normal tissue array, with TNM and grade, 24 cases 72 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BR727 |
Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011
|
US Biomax |
|
231 |
|
Publication |
 |
BR728 |
Breast carcinoma tissue array, with stage and grade info, 24 cases 72 cores, replacing BC08015
|
US Biomax |
|
231 |
|
Publication |
 |
BR801 |
Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores, replaced by BR804
|
US Biomax |
|
231 |
|
Publication |
 |
BR8010 |
Breast fibroadenoma tissue array (including normal, lobular, invasive carcinoma and metastasis in lymph nodes), 71 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BR8011 |
Breast intraductal carcinoma tissue microarray with normal adjacent tissue, 80 cases 80 cores
|
US Biomax |
|
314 |
|
Publication |
 |
BR8012 |
Breast cancer and normal tissue array with stage and grade info, 40 cases 80 cores, replaced by BR8014
|
US Biomax |
|
231 |
|
Publication |
 |
BR8013 |
Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BR8014 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012
|
US Biomax |
|
231 |
|
Publication |
 |
BR8015 |
Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014
|
US Biomax |
|
231 |
|
Publication |
 |
BR8016 |
Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BR8017 |
Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BR8018 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014
|
US Biomax |
|
266 |
|
Publication |
 |
BR802 |
Breast cancer tissue array, with matched or unmatched adjacent normal tissue array, 40 cases 80 cores, no overlaps with BR801, BR803 and BR1001, replaced by BR802b
|
US Biomax |
|
231 |
|
Publication |
 |
BR802b |
Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases 80cores, replacing BR802
|
US Biomax |
|
266 |
|
Publication |
 |
BR803 |
Breast carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores, replacing BC08016
|
US Biomax |
|
189 |
|
Publication |
 |
BR803a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed
|
US Biomax |
|
258 |
|
Publication |
 |
BR804 |
Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BR804a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed
|
US Biomax |
|
267 |
|
Publication |
 |
BR805 |
Breast infiltrating lobular carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BR806 |
Breast hyperplasia tissue array, 80 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BR807 |
Medullary carcinoma of breast tissue array, 80 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BR808 |
Tissue array of multiple types of breast cancer and normal breast tissue, 80 cases 80 cores, replaced by BR8018
|
US Biomax |
|
231 |
|
Publication |
 |
BR809 |
Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
 |
BR811 |
Breast cancer tissue array with normal tissues from autopsy, 80 cases 80 cores, with grade and stage data
|
US Biomax |
|
231 |
|
Publication |
 |
BR812 |
Breast cancer tissue array with normal tissues from autopsy, 40 cases 80 cores, with TNM data
|
US Biomax |
|
231 |
|
Publication |
 |
BR951 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95
|
US Biomax |
|
456 |
|
Publication |
 |
BR952 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores
|
US Biomax |
|
456 |
|
Publication |
 |
BR953 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952
|
US Biomax |
|
456 |
|
Publication |
 |
BR954 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc
|
US Biomax |
|
429 |
|
Publication |
 |
BR961 |
Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replaced by BR962
|
US Biomax |
|
0 |
|
Publication |
 |
BR962 |
Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replacing BR961, BR701
|
US Biomax |
|
231 |
|
Publication |
 |
BR963 |
Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962
|
US Biomax |
|
314 |
|
Publication |
 |
BR963a |
Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed
|
US Biomax |
|
296 |
|
Publication |
 |
BR964 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228 |
|
Publication |
 |
BRC1021 |
Breast cancer tissue array, 102 cases 102 cores
|
US Biomax |
|
225 |
|
Publication |
 |
BRC1501 |
Breast cancer mid density tissue array, non overlapping with either BRC1502 or BRC1503, 75 cases 150 cores
|
US Biomax |
|
225 |
|
Publication |
 |
BRC1502 |
Breast cancer mid density tissue array, non overlapping with either BRC1501 or BRC1503, 75 cases 150 cores
|
US Biomax |
|
225 |
|
Publication |
 |
BRC1503 |
Breast cancer mid density tissue array, non overlapping with BRC1501 or BRC1502, 75 cases 150 cores
|
US Biomax |
|
225 |
|
Publication |
 |
BRC2281 |
High density breast cancer tissue array, 228 cases 228 cores
|
US Biomax |
|
0 |
|
Publication |
 |
BRC481 |
Breast cancer and normal tissue array, 16 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
 |
BRC491 |
Human breast invasive ductal carcinoma (IDC) tissue array, non overlapping with BRC711, 49 cases 49 cores
|
US Biomax |
|
142 |
|
Publication |
 |
BRC51 |
Breast cancer tissue array BLOCK, Her-2 IHC marker; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
4878 |
|
Publication |
 |
BRC711 |
Human breast invasive ductal cancer tissue array, non overlapping with BRC491, 71 cases 72 cores
|
US Biomax |
|
142 |
|
Publication |
 |
BRC961 |
Breast cancer array with normal and other non malignant breast tissues, non overlapping with BRC962, with AR ER PR Her 2(neu) IHC results, 48 cases 96 cores
|
US Biomax |
|
225 |
|
Publication |
 |
BRC962 |
Breast cancer and normal tissue array, non overlapping with BRC961, with TNM data, 48 cases 96 cores
|
US Biomax |
|
225 |
|
Publication |
 |
BRD181 |
Breast disease tissue array, 18 cases 18 cores
|
US Biomax |
|
118 |
|
Publication |
 |
BRF401 |
Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmed
|
US Biomax |
|
742 |
|
Publication |
 |
BRF404 |
Breast invasive ductal carcinoma forzen tissue array, 20 cases 40 cores
|
US Biomax |
|
167 |
|
Publication |
 |
BRM481 |
Tissue array of breast carcinoma metastasis in lymph nodes, 24 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
 |
BRM961 |
Breast cancer tissue array containing primary and matched metastatic tumors (in lymph nodes) and adjacent normal breast tissue, 48 casea 96 cores
|
US Biomax |
|
314 |
|
Publication |
 |
BRN801 |
Breast normal adjacent tissue and cancer tissue array, 80 cases 80 cores, replacing BN08013
|
US Biomax |
|
231 |
|
Publication |
 |
BRN801a |
Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed
|
US Biomax |
|
258 |
|
Publication |
 |
BS01011 |
Stomach cancer tissue array, 72 cases 72 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BS01012 |
Stomach adenocarcinoma tissue array, 72 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BS01032 |
Stomach adenocarcinoma (grade II) tissue array, 63 cases 63 cores, replaced by ST808
|
US Biomax |
|
160 |
|
Publication |
 |
BS01041 |
Stomach adenocarcinoma (grade III) tissue array, 22 cases 63 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BS01042 |
Stomach adenocarcinoma (grade III) tissue array, 22 cases 63 cores, replaced by ST723
|
US Biomax |
|
160 |
|
Publication |
 |
BS02021 |
Esophagus squamous cell carcinoma (grade I) tissue array, 21 cases 63 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BS02031 |
Esophagus squamous cell carcinoma (grade II) tissue array, 22 cases 63 cores, replaced by ES723
|
US Biomax |
|
160 |
|
Publication |
 |
BS02041 |
Esophagus squamous cell carcinoma (grade III) tissue array, 23 cases 63 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BS02051 |
Esophagus adenocarcinoma tissue array, 33 cases 63 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BS03011 |
Hepatocellular carcinoma tissue array, 21 cases 63 cores, replaced by LV804
|
US Biomax |
|
160 |
|
Publication |
 |
BS03013 |
Hepatocellular carcinoma tissue array, 22 cases 63 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BS03014 |
Hepatocellular carcinoma tissue array, 63 cases 63 cores, replaced by LV809
|
US Biomax |
|
160 |
|
Publication |
 |
BS04011 |
Lung squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by LC808
|
US Biomax |
|
160 |
|
Publication |
 |
BS04031 |
Lung squamous cell carcinoma tissue array, 63 cases 64 cores, replaced by LC724
|
US Biomax |
|
160 |
|
Publication |
 |
BS04041 |
Lung squamous cell carcinoma (grade II) tissue array, 21 cases 63 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BS04071 |
Lung squamous cell carcinoma (grade III) tissue array, 21 cases 63 cores, replaced by LC723
|
US Biomax |
|
160 |
|
Publication |
 |
BS04081 |
Lung adenocarcinoma (grade II) tissue array, 21 cases 63 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BS04102 |
Large cell carcinoma of lung tissue array, 21 cases 63 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BS04111 |
Lung small cell carcinoma tissue array, 33 cases 63 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BS05011 |
Colon adenocarcinoma tissue array, 23 cases 63 cores.
|
US Biomax |
|
160 |
|
Publication |
 |
BS05021 |
Colon adenocarcinoma (grade I) tissue array, 23 cases 63 cores, replaced by CO723
|
US Biomax |
|
160 |
|
Publication |
 |
BS05031 |
Colon adenocarcinoma (grade II) tissue array, 21 cases 63 cores, replaced by CO724
|
US Biomax |
|
160 |
|
Publication |
 |
BS05041 |
Colon adenocarcinoma (grade III) tissue array, 23 cases 63 cores, replaced by CO725
|
US Biomax |
|
189 |
|
Publication |
 |
BS06011 |
Rectum adenocarcinoma tissue array, 22 cases 63 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BS06021 |
Rectum adenocarcinoma (grade I) tissue array, 21 cases 63 cores
|
US Biomax |
|
160 |
|
Publication |
 |
BS06031 |
Rectum adenocarcinoma (grade II) tissue array, 21 cases 63 cores, replaced by RE723
|
US Biomax |
|
160 |
|
Publication |
 |
BS06041 |
Rectum adenocarcinoma (grade III) tissue array, 21 cases 63 cores, replaced by RE724
|
US Biomax |
|
160 |
|
Publication |
 |
BS08011 |
Breast infiltrating ductal carcinoma tissue array, 22 cases 63 cores, replaced by BR727
|
US Biomax |
|
160 |
|
Publication |
 |
BS09011 |
Uteral leiomyoma (hysteromyoma) tissue array, 30 cases 60 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BS17011 |
Brain glioblastoma tissue array, 21 cases 63 cores, replaced by GL811
|
US Biomax |
|
231 |
|
Publication |
 |
BS17015 |
Brain glioma tissue array, 63 cases 63 cores, replaced by GL803
|
US Biomax |
|
231 |
|
Publication |
 |
BS17016 |
Brain glioma tissue array, 33 cases 63 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BS17016a |
Brain glioblastoma tissue array, including pathology grade, 40 cases 80 cores, replacing BS17016; ihc Anti-Actin confirmed
|
US Biomax |
|
267 |
|
Publication |
 |
BS17017 |
Brain gliocytoma tissue array, 63 cases 63 cores
|
US Biomax |
|
231 |
|
Publication |
 |
BS17018 |
Brain glioblastoma tissue array, 33 cases 63 cores, replaced by GL805
|
US Biomax |
|
231 |
|
Publication |
 |
BS20011 |
Lymphoma tissue array, 30 cases 30 cores, replaced by NHL481
|
US Biomax |
|
189 |
|
Publication |
 |
BS26011 |
Osteosarcoma tissue array, 32 cases 63 cores, replaced by OS804
|
US Biomax |
|
231 |
|
Publication |
 |
BS36011 |
Cartilages sarcoma (Chondrosarcoma) tissue array, 25 cases 75 cores, replaced by OS803
|
US Biomax |
|
266 |
|
Publication |
 |
CIN481 |
Cervical intraepithelial neoplasia tissue array with cervical disease spectrum, 48 cases 48 cores
|
US Biomax |
|
225 |
|
Publication |
 |
CKIT061 |
Ckit molecule IHC control array, 3 cases 6 cores
|
US Biomax |
|
77 |
|
Publication |
 |
CLC601 |
Colon cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases 60 cores
|
US Biomax |
|
266 |
|
Publication |
 |
CM241 |
Common 4 types of cancer tissue array, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
 |
CM481 |
Common 4 types of cancer tissue array, 48 cases 54 cores, with stage and grade data
|
US Biomax |
|
231 |
|
Publication |
 |
CMA241 |
Human tumor cell array, 12 cell lines 24 cores
|
US Biomax |
|
278 |
|
Publication |
 |
CMA241a |
Human tumor cell array, 12 cell lines 24 cores, replacing CMA241; ihc Anti-Actin confirmed
|
US Biomax |
|
267 |
|
Publication |
 |
CNS2081 |
Central nerve disease spectrum (central nerve tumor progression) tissue array, 104 cases 208 cores
|
US Biomax |
|
516 |
|
Publication |
 |
CNS801 |
Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases 80 cores
|
US Biomax |
|
314 |
|
Publication |
 |
CO1002 |
Colon and rectum carcinoma and normal tissue array, 73 cases 100 cores, replaced by CO1002b
|
US Biomax |
|
278 |
|
Publication |
 |
CO1002b |
Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases 100 cores, replacing CO1002
|
US Biomax |
|
321 |
|
Publication |
 |
CO1003 |
Colon carcinoma antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax |
|
231 |
|
Publication |
 |
CO1004 |
Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231 |
|
Publication |
 |
CO1021 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
296 |
|
Publication |
 |
CO1501 |
Colon adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321 |
|
Publication |
 |
CO1502 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258 |
|
Publication |
 |
CO1921 |
High density colon cancer tissue array with normal tissues, 192 cases 192 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CO1922 |
Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CO2001 |
Colon cancer high density tissue array, including TNM and pathology grade, 196 cases 200 core
|
US Biomax |
|
397 |
|
Publication |
 |
CO208 |
High density, multiple colon cancer (1 4 grade) and normal colon tissue array, 70 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CO2081 |
Colon disease spectrum (colon cancer progression) tissue array, including TNM and pathology grade, 103 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CO20810 |
Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CO20811 |
Colon tumor survey tissue array (1 of 4), including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CO20812 |
Colon tumor survey tissue array (2 of 4), including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CO20813 |
Colon tumor survey tissue array (3 of 4), including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CO20814 |
Colon tumor survey tissue array (4 of 4), including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CO2083 |
High density colon cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CO2085a |
High density (208 cases 208 cores), multiple type colon adenocarcinoma (I 4 grade) tissue array with normal colon from autopsy and cancer adjacent tissue
|
US Biomax |
|
456 |
|
Publication |
 |
CO2085b |
TMA BLOCK of high density (208 cases 208 cores), multiple type colon adenocarcinoma (I 4 grade) with normal colon from autopsy and cancer adjacent tissue
|
US Biomax |
|
40981 |
|
Publication |
 |
CO2086 |
Colon tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CO2087 |
Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CO2088 |
Colon cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CO2089 |
Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CO208b |
TMA Block of high density (70 cases 208 cores), multiple colon cancer (1 4 grade) and normal colon tissue array block
|
US Biomax |
|
40981 |
|
Publication |
 |
CO2161 |
Colon cancer and normal colon tissue array, including TNM and pathology grade, 216 cases 216 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CO241 |
Colon cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
 |
CO241a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed
|
US Biomax |
|
105 |
|
Publication |
 |
CO242 |
Multiple colon cancer test tissue array with self matching normal adjacent tissue, 10 cases 24 cores.
|
US Biomax |
|
88 |
|
Publication |
 |
CO242a |
Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed
|
US Biomax |
|
81 |
|
Publication |
 |
CO243 |
Colon cancer tissue array with normal tissue controls, 9 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
 |
CO243a |
Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed
|
US Biomax |
|
105 |
|
Publication |
 |
CO244 |
Colon cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
 |
CO481 |
Colonic adenocarcinoma and matched adjacent tissue array, with TNM data, 12 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
 |
CO482 |
Tissue array of colonic carcinoma with TNM data and normal colon tissue, 24 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
 |
CO483 |
Multiple colon cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade information
|
US Biomax |
|
160 |
|
Publication |
 |
CO484 |
Colon cancer tissue array with normal tissues with TNM and grade, 48 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
 |
CO484a |
Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed
|
US Biomax |
|
210 |
|
Publication |
 |
CO485 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores
|
US Biomax |
|
231 |
|
Publication |
 |
CO486 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores
|
US Biomax |
|
397 |
|
Publication |
 |
CO487 |
Colon adenocarcinoma with matched adjacent colon tissue array, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225 |
|
Publication |
 |
CO488 |
Colon adenocarcinoma with matched adjacent colon tissue array, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
185 |
|
Publication |
 |
CO6161 |
High density colon cancer array, with stage, grade and normal colon tissue, 322 cases 616 cores
|
US Biomax |
|
753 |
|
Publication |
 |
CO641 |
Colon cancer tissue array, 64 cases 66 cores, with TNM data
|
US Biomax |
|
0 |
|
Publication |
 |
CO701 |
Colon cancer tissue array, with grade 1 4 and normal colon tissue, 70 cases 70 cores, with stage and grade information
|
US Biomax |
|
231 |
|
Publication |
 |
CO702 |
Colon cancer tissue array, with metastasis tissue and adjacent normal tissue, including TNM and pathology grade, 69 cases 69 cores, repalcing BC05115
|
US Biomax |
|
266 |
|
Publication |
 |
CO721 |
Colon cancer tissue array with stage and grade info, 24 cases 72 cores
|
US Biomax |
|
231 |
|
Publication |
 |
CO722 |
Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases 72 cores, replacing BC05021
|
US Biomax |
|
231 |
|
Publication |
 |
CO723 |
Colon well differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05021
|
US Biomax |
|
231 |
|
Publication |
 |
CO724 |
Colon moderately differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05031
|
US Biomax |
|
278 |
|
Publication |
 |
CO725 |
Colon poorly differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05041
|
US Biomax |
|
231 |
|
Publication |
 |
CO726 |
Metastatic colon carcinoma tissue array, 24 cases 72 cores, replacing BC050112
|
US Biomax |
|
266 |
|
Publication |
 |
CO801 |
Colon cancer tissue array, with matched or unmatched adjacent normal tissue, 40 cases 80 cores, no overlaps with CO802
|
US Biomax |
|
231 |
|
Publication |
 |
CO802 |
Colon carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with CO801
|
US Biomax |
|
189 |
|
Publication |
 |
CO802a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed
|
US Biomax |
|
258 |
|
Publication |
 |
CO803 |
Colon cancer tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
CO804 |
Multiple types of colon carcinoma tissue array (replacing BC05011), 80 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
CO804a |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed
|
US Biomax |
|
267 |
|
Publication |
 |
CO805 |
Colon adenocarcinoma and normal tissue array with stage and grade information, 40 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
CO806 |
Colon normal adjacent tissue array, replacing BN05012, 80 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
CO807 |
Advanced colon cancer tissue array, with stage and grade info, 80 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
 |
CO808 |
Colon disease spectrum (colon cancer progression) tissue array, 76 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
 |
CO809 |
Colon polyp and colitis tissue array, including colon adenoma and normal tissue, 80 cases 80 cores
|
US Biomax |
|
263 |
|
Publication |
 |
CO811 |
Colon cancer tissue array with normal tissues from autopsy, with TNM data, 80 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
CO812 |
Colon carcinoma and normal tissue array, 80 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
CO951 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CO952 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi
|
US Biomax |
|
429 |
|
Publication |
 |
CO962 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258 |
|
Publication |
 |
CO991 |
Colorectal (colon and rectum) cancer with matched lymph node metastasis tissue array, 44 cases 99 cores.
|
US Biomax |
|
266 |
|
Publication |
 |
CO992 |
Colorectal (colon and rectum) cancer with matched lymph node metastasis and normal adjacent tissue array, 43 cases 99 cores
|
US Biomax |
|
266 |
|
Publication |
 |
COC1021 |
Colon cancer tissue array, 102 cases 102 cores
|
US Biomax |
|
225 |
|
Publication |
 |
COC1501 |
Colon cancer mid density tissue array, non overlapping with either COC1502 or COC1503, 75 cases 150 cores
|
US Biomax |
|
0 |
|
Publication |
 |
COC1502 |
Colon cancer mid density tissue array, non overlapping with either COC1501 or COC1503 75 cases 150 cores
|
US Biomax |
|
0 |
|
Publication |
 |
COC1503 |
Colon cancer mid density tissue array, non overlapping with either COC1501 or COC1502, 75 cases 150 cores
|
US Biomax |
|
225 |
|
Publication |
 |
COC2281 |
High density colon cancer tissue array, 228 cases 228 cores
|
US Biomax |
|
0 |
|
Publication |
 |
COC481 |
Colon cancer and normal tissue array, non overlapping with COC482 16 cases 48 cores
|
US Biomax |
|
166 |
|
Publication |
 |
COC482 |
Colon cancer and normal tissue array, non overlapping with COC481 16 cases 48 cores
|
US Biomax |
|
166 |
|
Publication |
 |
COC961 |
Colon cancer and normal tissue array, non overlapping with COC962 48 cases 96 cores
|
US Biomax |
|
189 |
|
Publication |
 |
COC962 |
Colon cancer and normal tissue array, non overlapping with COC961, 48 cases 96 cores
|
US Biomax |
|
189 |
|
Publication |
 |
CR1001 |
Multiple uterine carcinoma tissue array with normal tissue, 49 cases 100 cores
|
US Biomax |
|
231 |
|
Publication |
 |
CR1002 |
Cervix carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax |
|
231 |
|
Publication |
 |
CR1003 |
Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231 |
|
Publication |
 |
CR1501 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258 |
|
Publication |
 |
CR1921 |
Middle advanced stage uterine cervix cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CR208 |
Cervical cancer high density tissue array, with normal cervix tissue as control, 69 cases 208 cores, with grade and stage
|
US Biomax |
|
456 |
|
Publication |
 |
CR2081 |
High density cervix cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CR2082 |
High density cervical cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CR2083 |
Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CR2084 |
Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CR2085 |
Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CR2086 |
Cervix tumor tissue array (4 of 5), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CR2087 |
Uterine cervical cancer tissue survey tissue array (5 of 5), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CR2088 |
Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CR2089 |
Cervix cancer survey tissue array (2 of 2), including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
CR241 |
Cervix cancer test tissue array with self matching or unmatched normal adjacent tissue, 11 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
 |
CR242 |
Multiple cervix cancer test tissue array with self matching or unmatched normal adjacent tissues, 22 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
 |
CR243 |
Uterine cervix cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections slide
|
US Biomax |
|
160 |
|
Publication |
 |
CR244 |
Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241
|
US Biomax |
|
189 |
|
Publication |
 |
CR245 |
Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105 |
|
Publication |
 |
CR481 |
Cervical cancer tissue array with normal adjacent tissues, 24 cases 48 cores, with grade and stage data
|
US Biomax |
|
160 |
|
Publication |
 |
CR482 |
Multiple cervix cancer tissue array with 4 normal tissues control from autopsy, 24 cases 48 cores, with grade and stage data
|
US Biomax |
|
160 |
|
Publication |
 |
CR483 |
Multiple cervix cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with TNM data
|
US Biomax |
|
160 |
|
Publication |
 |
CR484 |
Cervix squamous cell carcinoma tissue array with matched adjacent cervix tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225 |
|
Publication |
 |
CR485 |
Cervix cancer and adjacent normal tissue array, including TNM and pathology grade, 48 cases 48 cores
|
US Biomax |
|
231 |
|
Publication |
 |
CR501 |
Cervical cancer and normal tissue array with TNM and grade, 50 cases 50 cores
|
US Biomax |
|
160 |
|
Publication |
 |
CR601 |
Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I III), 59 cases 60 cores, replaced by CR602
|
US Biomax |
|
231 |
|
Publication |
 |
CR602 |
Tissue array of uterine cervical disease spectrum (cervical cancer, CIN, inflammation and adjacent normal tissue), 60 cases 60 cores, replacing CR601
|
US Biomax |
|
231 |
|
Publication |
 |
CR6161 |
High density uterine cervix cancer array, with stage, grade and normal cervical tissue, 322 cases 616 cores
|
US Biomax |
|
872 |
|
Publication |
 |
CR701 |
Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases 70 cores
|
US Biomax |
|
266 |
|
Publication |
 |
CR721 |
Uterine cervix cancer and normal tissue array, with grade and stage data, 24 cases 72 cores
|
US Biomax |
|
231 |
|
Publication |
 |
CR802 |
Cervical cancer tissue array, matched or unmatched tumor and adjacent normal tissue, 74 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
CR803 |
Multiple (uterine cervix) cervical squamous cancer tissue array, 80 cases 80 cores, replacing BS10011
|
US Biomax |
|
231 |
|
Publication |
 |
CR804 |
Cervical cancer and normal tissue array with TNM and grade, 40 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
CR805 |
Cervix cancer and normal tissue array, with stage and grade info, 80 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
CR806 |
Mid advanced stage uterine cervix cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
 |
CR811 |
Cervical cancer tissue array with normal tissues from autopsy, 40 cases 80 cores, with grade and TNM data
|
US Biomax |
|
231 |
|
Publication |
 |
CVD231 |
Cardiovascular disease tissue array, non overlapping with CVD481, 23 cases 23 cores
|
US Biomax |
|
166 |
|
Publication |
 |
CVD481 |
Cardiovascular disease tissue array, no overlapping with CVD231, 24 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
 |
CXC1021 |
Cervix cancer tissue array, 102 cases 102 cores
|
US Biomax |
|
225 |
|
Publication |
 |
CXC1501 |
Cervical cancer mid density tissue array, 75 cases 150 cores
|
US Biomax |
|
225 |
|
Publication |
 |
CXC241 |
Cervical cancer tissue array, 12 cases 24 cores
|
US Biomax |
|
189 |
|
Publication |
 |
CXC481 |
Cervix cancer and normal tissue array, 16 cases 48 cores
|
US Biomax |
|
225 |
|
Publication |
 |
CXC961 |
Cervical cancer and normal tissue array, non overlapping with CXC962, 48 cases 96 cores
|
US Biomax |
|
225 |
|
Publication |
 |
CXC962 |
Cervical cancer and normal tissue array, non overlapping with CXC961, 48 cases 96 cores
|
US Biomax |
|
225 |
|
Publication |
 |
CyFDA |
FDA normal organ tissue array of cynomolgus monkey, 99 cases 99 cores
|
US Biomax |
|
314 |
|
Publication |
 |
CyFDA1 |
FDA multiple organ normal tissue array of cynomolgus monkey, 34 organs 99 cores, replacing CyFDA; ihc Anti-Actin confirmed
|
US Biomax |
|
296 |
|
Publication |
 |
DGS2081 |
Digestive system tissue array, including TNM, stage and grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
DID381 |
Digestive system disease tissue array, 38 cases 38 cores
|
US Biomax |
|
166 |
|
Publication |
 |
DOG1061 |
GIST DOG1 molecule IHC control array, 3 cases 6 cores
|
US Biomax |
|
77 |
|
Publication |
 |
EM1021 |
Endometrium cancer and normal tissue array, including TNM and pathology grade, 102 cases 102 cores
|
US Biomax |
|
314 |
|
Publication |
 |
EMC1021 |
Endometrial cancer tissue array, 102 caese 102 cores
|
US Biomax |
|
225 |
|
Publication |
 |
EMC1501 |
Endometrial cancer mid density tissue array, non overlapping with EMC1502, 75 cases 150 cores
|
US Biomax |
|
225 |
|
Publication |
 |
EMC1502 |
Endometrial cancer mid density tissue array, non overlapping with EMC1501, 75 caese 150 cores
|
US Biomax |
|
225 |
|
Publication |
 |
EMC241 |
Endometrium cancer tissue array, 12 cases 24 cores
|
US Biomax |
|
189 |
|
Publication |
 |
EMC961 |
Endometrial cancer and normal tissue array, non overlapping with EMC962, 48 cases 96 cores
|
US Biomax |
|
225 |
|
Publication |
 |
EMC962 |
Endometrial cancer and normal tissue array, non overlapping with EMC961 48 cases 96 cores
|
US Biomax |
|
225 |
|
Publication |
 |
EN801 |
Endocrine tumor tissue array, 40 cases 80 cores.
|
US Biomax |
|
266 |
|
Publication |
 |
EN801a |
Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed
|
US Biomax |
|
296 |
|
Publication |
 |
ENS2081 |
Endocrine system benign, alignant tumor and normal tissue array, including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
ERC031 |
Estrogen receptor IHC control array, 3 cases 3 cores
|
US Biomax |
|
77 |
|
Publication |
 |
ES1001 |
Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax |
|
266 |
|
Publication |
 |
ES1002 |
Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
266 |
|
Publication |
 |
ES1201 |
Tissue array of esophageal squamous carcinoma and matched adjacent tissue, 60 cases 120 cores, replaced by ES1202
|
US Biomax |
|
278 |
|
Publication |
 |
ES1202 |
Esophageal tumor tissue array, with stage, grade and matched adjacent tissue, 60 cases 120 cores, replacing ES1201
|
US Biomax |
|
278 |
|
Publication |
 |
ES1501 |
Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321 |
|
Publication |
 |
ES1502 |
Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258 |
|
Publication |
 |
ES1921 |
Middle advanced stage esophagus cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456 |
|
Publication |
 |
ES2001 |
Esophagus squamous cell carcinoma and metastatic carcinoma tissue array, with adjacent tissue and adjacent normal tissue, including TNM and pathology grade, 120 cases 200 cores
|
US Biomax |
|
516 |
|
Publication |
 |
ES208 |
High density esophageal cancer tissue array, with normal tissue, grade and TNM, 69 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
ES2081 |
Esophageal disease (progression) spectrum tissue array, 103 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
ES2082 |
High density esophageal cancer and normal tissue array, with TNM and grade info, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
 |
ES241 |
Esophagus cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
 |
ES242 |
Multiple esophagus cancer test tissue array with matched or unmatched normal adjacent tissue, 11 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
 |
ES243 |
Esophagus cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
 |
ES244 |
Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90 |
|
Publication |
 |
ES481 |
Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases 48 cores) with stage and grade info; ihc Anti-Actin confirmed
|
US Biomax |
|
210 |
|
Publication |
 |
ES482 |
Multiple esophagus cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores, with grade and stage data
|
US Biomax |
|
160 |
|
Publication |
 |
ES483 |
Esophagus cancer and matched adjacent tissue array, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
 |
ES721 |
Esophagus cancer and normal tissue array with TNM and grade info, 24 cases 72 cores
|
US Biomax |
|
231 |
|
Publication |
 |
ES722 |
Esophageal cancer and adjacent tissue array, with stage and grade info, 30 cases 72 cores, replacing BC02023
|
US Biomax |
|
231 |
|
Publication |
 |
ES723 |
Esophageal squamous cell carcinoma tissue array, with stage, grade and normal tissue, 23 cases 72 cores, replacing BS02031
|
US Biomax |
|
231 |
|
Publication |
 |
ES781 |
Esophagus cancer tissue array, including TNM and pathology grade, 26 cases 78 cores, replacing BC02111
|
US Biomax |
|
266 |
|
Publication |
 |
ES801 |
Esophagus cancer, with matched normal adjacent tissue array, 40 cases 80 cores, replaced by ES8010
|
US Biomax |
|
231 |
|
Publication |
 |
ES8010 |
Esophageal cancer and adjacent normal tissue array, with TNM and grade info, 40 cases 80 cores, replacing ES801
|
US Biomax |
|
231 |
|
Publication |
 |
ES8011 |
Esophageal cancer tissue array, with normal tissue, TNM and grade info, 40 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
ES8012 |
Middle advanced stage esophageal cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores
|
US Biomax |
|
278 |
|
Publication |
 |
ES802 |
Esophageal squamous cell carcinoma tissue array, grade I III, 40 cases 80 cores, no overlaps with ES801
|
US Biomax |
|
231 |
|
Publication |
 |
ES803 |
Esophageal inflammation, hyperplasia and atypical hyperplasia tissue array, 80 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
ES804 |
Esophageal cancer progression tissue array, 76 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
ES805 |
Esophagus cancer and normal tissue array, with grade and stage data, 40 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
ES806 |
Metastatic esophageal cancer tissue array, 40 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
ES807 |
Esophageal cancer and normal tissue array, with stage and grade info, 80 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
ES808 |
Esophagus cancer and normal tissue array, with TNM and grade info, 78 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
ES809 |
Esophageal disease spectrum (esophageal cancer progression) tissue array, 78 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
ES810 |
Esophagus cancer with matched lymph node metastasis tissue array, 40 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
 |
ES811 |
Esophageal cancer tissue array with normal tissues from autopsy, 40 cases 80 cores, plus grade and stage information
|
US Biomax |
|
231 |
|
Publication |
 |
ES961 |
Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores
|
US Biomax |
|
336 |
|
Publication |
 |
ES962 |
Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258 |
|
Publication |
 |
ESC1021 |
Esophagus cancer tissue array, 102 cases 102 cores
|
US Biomax |
|
225 |
|
Publication |
 |
ESC1501 |
Esophageal cancer mid density tissue array, non overlapping with ESC1502 75 cases 150 cores
|
US Biomax |
|
225 |
|
Publication |
 |
ESC1502 |
Esophagus cancer mid density tissue array, non overlapping with ESC1501, 75 cases 150 cores
|
US Biomax |
|
0 |
|
Publication |
 |
ESC241 |
Esophagus cancer tissue array, 12 cases 24 cores
|
US Biomax |
|
166 |
|
Publication |
 |
ESC242 |
Esophagus cancer tissue array, 12 cases 24 cores; ihc H&E, IHC anti-Cytokeratin
|
US Biomax |
|
205 |
|
Publication |
 |
ESC481 |
Esophagus cancer and normal tissue array, 16 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
 |
ESC961 |
Esophageal cancer tissue array, non overlapping with ESC962, 48 cases 96 cores
|
US Biomax |
|
189 |
|
Publication |
 |
ESC962 |
Esophagus cancer tissue array, non overlapping with ESC961, 48 cases 96 cores
|
US Biomax |
|
189 |
|
Publication |
 |
FBN401 |
Normal human multiple organ frozen tissue array (20 organs in duplicate), 20 cases 40 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
278 |
|
Publication |
 |
FBN404 |
Multiple organ normal frozen tissue array, 20 cases 40 cores
|
US Biomax |
|
167 |
|
Publication |
 |
FBN406 |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404
|
US Biomax |
|
167 |
|
Publication |
 |
FBN406a |
Multiple organ normal frozen tissue array, 20 organs 40 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
394 |
|
Publication |
 |
FBN407 |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404
|
US Biomax |
|
281 |
|
Publication |
 |
FBN407a |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replaing FBN407; ihc Anti-Actin confirmed
|
US Biomax |
|
626 |
|
Publication |
 |
FCO401 |
Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a
|
US Biomax |
|
293 |
|
Publication |
 |
FCO401a |
Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401
|
US Biomax |
|
781 |
|
Publication |
 |
FDA800 |
Multiple organ tumor tissue array, 72 cases of variety of cancers 72 cores, replacing FDA802 2 or FDA803 2
|
US Biomax |
|
266 |
|
Publication |
 |
FDA801 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278 |
|
Publication |
 |
FDA802 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278 |
|
Publication |
 |
FDA803 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278 |
|
Publication |
 |
FDA804 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax |
|
278 |
|
Publication |
 |
FDA805 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax |
|
314 |
|
Publication |
 |
FDA805-2 |
Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2
|
US Biomax |
|
278 |
|
Publication |
 |
FDA806 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax |
|
380 |
|
Publication |
 |
FDA807 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296 |
|
Publication |
 |
FDA807-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2
|
US Biomax |
|
336 |
|
Publication |
 |
FDA808 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296 |
|